Sunday, November 22, 2026
28.1 C
Bengaluru

Pharmacy of the World Pricing Paradox

India occupies an extraordinary position in global pharmaceuticals. It supplies around 20 per cent of the world’s generic medicines by volume and is one of the world’s largest vaccine manufacturers. Government data published in 2026 says India supplies approximately 20 per cent of global generic medicines and 55–60 per cent of UNICEF’s vaccines. India also ranks third globally in pharmaceutical production by volume.

Yet India’s domestic pharmaceutical architecture contains an important paradox.

The country has built a globally significant export industry serving highly regulated markets while its domestic system simultaneously combines direct price regulation, fragmented public purchasing and a drug-quality regulatory structure divided between the Central Drugs Standard Control Organisation and State Licensing Authorities.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

USFDA Crackdown on Indian Pharma: Lessons for Indian Regulator

The US Food and Drug Administration has made unannounced...

The era of regulatory arbitrage in Indian nutraceuticals is officially over.

With the FSSAI suspending licenses across six nutraceutical manufacturers...

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Closing the Value Gap in Indian Pharma: What Doctors Really Want from Digital Engagement

Indian pharma is investing heavily in digital engagement. But...

Topics

USFDA Crackdown on Indian Pharma: Lessons for Indian Regulator

The US Food and Drug Administration has made unannounced...

The era of regulatory arbitrage in Indian nutraceuticals is officially over.

With the FSSAI suspending licenses across six nutraceutical manufacturers...

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...
spot_img

Related Articles

spot_imgspot_img